文献速递流行病学与生物统计基础与转化研究

低密度脂蛋白降低与收缩压降低联合暴露相关遗传变异与终生心血管疾病风险的关联

Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.
PubMed 文献 · JAMA · 2019-01-01

在UK Biobank的438 952名参与者中,利用遗传评分分组评估终生低LDL-C和低SBP暴露与主要冠脉事件风险的关系。LDL-C和SBP遗传评分均高于中位数者LDL-C低13.9 mg/dL、SBP低3.1 mmHg,主要冠脉事件OR为0.61(95%CI 0.59-0.64;P<.001)。作者结论认为终生遗传暴露于较低LDL-C和较低SBP与较低心血管风险相关,但这些发现不能假定代表治疗这些危险因素可获得的获益幅度。

要点

  • LDL-C遗传评分高于中位数者LDL-C低14.7 mg/dL,主要冠脉事件OR 0.73(95%CI 0.70-0.75)。
  • SBP遗传评分高于中位数者SBP低2.9 mmHg,主要冠脉事件OR 0.82(95%CI 0.79-0.85)。
  • 两评分均高于中位数者LDL-C低13.9 mg/dL、SBP低3.1 mmHg,主要冠脉事件OR 0.61(95%CI 0.59-0.64)。

核心结论

  • 终生遗传暴露于较低低密度脂蛋白胆固醇和较低收缩压与较低心血管风险相关。
  • 作者指出这些发现不能假定代表治疗这些危险因素可获得的获益幅度。

研究设计与样本

  • 研究纳入2006至2010年UK Biobank的438 952名参与者,随访至2018年。
  • 使用遗传LDL-C和SBP评分将参与者分为终生低LDL-C、低SBP或两者联合暴露组。
  • 比较组间血浆LDL-C、SBP和心血管事件率差异,以评估与终生心血管疾病风险的关联。

主要发现

  • 参与者平均年龄65.2岁(范围40.4-80.0岁),54.1%为女性,24 980人发生首次主要冠脉事件。
  • LDL-C遗传评分高于中位数者LDL-C低14.7 mg/dL,主要冠脉事件OR 0.73(95%CI 0.70-0.75;P<.001)。
  • SBP遗传评分高于中位数者SBP低2.9 mmHg,主要冠脉事件OR 0.82(95%CI 0.79-0.85;P<.001)。
  • 两评分均高于中位数者LDL-C低13.9 mg/dL、SBP低3.1 mmHg,主要冠脉事件OR 0.61(95%CI 0.59-0.64;P<.001)。
  • 在4×4析因分析中,遗传风险评分增加及LDL-C和SBP较低与主要冠脉事件风险剂量依赖性降低相关。

关键数值与推荐

  • Meta回归分析中,联合暴露于LDL-C低38.67 mg/dL和SBP低10 mmHg与主要冠脉事件OR 0.22相关(95%CI 0.17-0.26;P<.001)。
  • Meta回归分析中,联合暴露于LDL-C低38.67 mg/dL和SBP低10 mmHg与心血管死亡OR 0.32相关(95%CI 0.25-0.40;P<.001)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 作者指出这些发现不能假定代表治疗这些危险因素可获得的获益幅度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The relationship between exposure to lower low-density lipoprotein cholesterol (LDL-C) and lower systolic blood pressure (SBP) with the risk of cardiovascular disease has not been reliably quantified. OBJECTIVE: To assess the association of lifetime exposure to the combination of both lower LDL-C and lower SBP with the lifetime risk of cardiovascular disease. DESIGN, SETTING, AND PARTICIPANTS: Among 438 952 participants enrolled in the UK Biobank between 2006 and 2010 and followed up through 2018, genetic LDL-C and SBP scores were used as instruments to divide participants into groups with lifetime exposure to lower LDL-C, lower SBP, or both. Differences in plasma LDL-C, SBP, and cardiovascular event rates between the groups were compared to estimate associations with lifetime risk of cardiovascular disease. EXPOSURES: Differences in plasma LDL-C and SBP compared with participants with both genetic scores below the median. Genetic risk scores higher than the median were associated with lower LDL-C and lower SBP. MAIN OUTCOMES AND MEASURES: Odds ratio (OR) for major coronary events, defined as coronary death, nonfatal myocardial infarction, or coronary revascularization. RESULTS: The mean age of the 438 952 participants was 65.2 years (range, 40.4-80.0 years), 54.1% were women, and 24 980 experienced a first major coronary event. Compared with the reference group, participants with LDL-C genetic scores higher than the median had 14.7-mg/dL lower LDL-C levels and an OR of 0.73 for major coronary events (95% CI, 0.70-0.75; P < .001). Participants with SBP genetic scores higher than the median had 2.9-mm Hg lower SBP and an OR of 0.82 for major coronary events (95% CI, 0.79-0.85, P < .001). Participants in the group with both genetic scores higher than the median had 13.9-mg/dL lower LDL-C, 3.1-mm Hg lower SBP, and an OR of 0.61 for major coronary events (95% CI, 0.59-0.64; P < .001). In a 4 × 4 factorial analysis, exposure to increasing genetic risk scores and lower LDL-C levels and SBP was associated with dose-dependent lower risks of major coronary events. In a meta-regression analysis, combined exposure to 38.67-mg/dL lower LDL-C and 10-mm Hg lower SBP was associated with an OR of 0.22 for major coronary events (95% CI, 0.17-0.26; P < .001), and 0.32 for cardiovascular death (95% CI, 0.25-0.40; P < .001). CONCLUSIONS AND RELEVANCE: Lifelong genetic exposure to lower levels of low-density lipoprotein cholesterol and lower systolic blood pressure was associated with lower cardiovascular risk. However, these findings cannot be assumed to represent the magnitude of benefit achievable from treatment of these risk factors.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Ference BA, Bhatt DL, Catapano AL, et al. Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease. JAMA. 2019. PMID: 31475726. doi:10.1001/jama.2019.14120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。